Enteris BioPharma seeks to stand out from a pack of contract manufacturers with experience, flexibility, and quality. While much of market is focused on mammalian cell cultures, Enteris has “carved out their own niche” in microbial expression systems.
In the next few years, regulations will come on line requiring serialized packaging of...
Saranraj Sivabushnam of Beroe Consulting takes us through the opportunities and challenges for...
Pharmaceutical processors face a number of challenges in determining the direction they should take when considering internal investments – but a lack of options have never been amongst them.
Ensuring continuous supplies of near-pure nitrogen to deoxygenate water can be a time-efficient and cost-effective way to formulate today’s medicines.
While it’s a vital link between a facility and the pharmaceuticals shipped in and out every day, the loading dock presents the greatest opportunity for energy losses and damage to precious materials and products.
Shared service management is an important development in the collaboration between an organization’s supporting services, and can make an organization more Lean.
Downstream processing continues to impact capacity at the majority of biopharmaceutical manufacturing facilities, and industry respondents are clamoring for advances in this area.
Dow Development Laboratories, LLC positions itself as the go to company for topical product development services.
Get a taste of the year’s biggest event for pharmaceutical and biotechnology professionals with six pages of our Interphex Exhibitor Highlights. Page till the end to preview a schedule of convention workshops and events.
The globalization of the pharmaceutical industry means inspection and identification of incoming raw materials is more important than ever. While this could mean a hiccup in the production process, we give you a case study of how handheld Raman technology meant an opportunity for cost savings.
On the one hand, the drug manufacturing industry is expanding, with an increase in global imports and exports. On the other hand however, the drug manufacturing industry is becoming more specialized.
Thanks for sparing some time in your busy day to visit our site or check out one of our daily newsletters. In respect to that dynamic, I’ll be brief in sharing some of the new things we’re doing to improve the daily content mix.
The impact of work-in-process (WIP) on oral solid dosage (OSD) plant design
Defining categories for potency of pharmaceutical compounds has been invaluable to our industry. It allows R&D to evaluate and define the potency of new compounds so they may be handled safely.
Manually executed cleaning techniques and procedures have been utilized to wash small change parts and equipment since the inception of oral solid dosage manufacturing.
Modularization has been explored and exploited in the delivery of pharmaceutical facilities for many years; the concept can now be considered mature.
There are many nuances that require a more focused approach to risk identification and project management for the “new” manufacturing facilities implementing Single-use Systems (SUS).